PRESENCE OF RISK FACTORS ASSOCIATED WITH COLECTOMY AMONG PATIENTS WITH COLECTOMY IN THE TOFACITINIB OCTAVE ULCERATIVE COLITIS CLINICAL PROGRAMME

David T. Rubin  1     Leonardo Salese  2     Paulo Kotze  3     John C. Woolcott  3     Chinyu Su  3     Rajiv Mundayat  4     Jerome Paulissen  4     Joana Torres  5     Millie Long  6    
1 University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States
2 Pfizer Inc, Collegeville, United States
3 IBD Outpatient Clinics, Colorectal Surgery Unit, Catholic University of Paraná, Curitiba, Brazil
4 Pfizer Inc, New York, United States
5 Gastroenterology Division, Hospital Beatriz Ângelo, Loures, Portugal
6 University of North Carolina, Center for Gastrointestinal Biology and Disease, Chapel Hill, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing